These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Esophagoprotective activity of angiotensin-(1-7) in experimental model of acute reflux esophagitis. Evidence for the role of nitric oxide, sensory nerves, hypoxia-inducible factor-1alpha and proinflammatory cytokines. Pawlik MW; Kwiecien S; Pajdo R; Ptak-Belowska A; Brzozowski B; Krzysiek-Maczka G; Strzalka M; Konturek SJ; Brzozowski T J Physiol Pharmacol; 2014 Dec; 65(6):809-22. PubMed ID: 25554985 [TBL] [Abstract][Full Text] [Related]
23. The effect of cisapride in patients with reflux esophagitis: an ambulatory esophageal manometry/pH-metry study. Paterson WG; Wang H; Beck IT Am J Gastroenterol; 1997 Feb; 92(2):226-30. PubMed ID: 9040196 [TBL] [Abstract][Full Text] [Related]
24. Characterization of acid and alkaline reflux in patients with Barrett's esophagus. G.O.S.P.E. Operative Group for the study of Esophageal Precancer. D'Onofrio V; Bovero E; Iaquinto G Dis Esophagus; 1997 Jan; 10(1):16-22; discussion 22-3. PubMed ID: 9079268 [TBL] [Abstract][Full Text] [Related]
25. Nitric oxide (NO)-releasing aspirin exhibits a potent esophagoprotection in experimental model of acute reflux esophagitis. Role of nitric oxide and proinflammatory cytokines. Pawlik M; Pajdo R; Kwiecien S; Ptak-Belowska A; Sliwowski Z; Mazurkiewicz-Janik M; Konturek SJ; Pawlik WW; Brzozowski T J Physiol Pharmacol; 2011 Feb; 62(1):75-86. PubMed ID: 21451212 [TBL] [Abstract][Full Text] [Related]
26. Pathogenesis of esophagitis in patients with gastroesophageal reflux. Little AG; DeMeester TR; Kirchner PT; O'Sullivan GC; Skinner DB Surgery; 1980 Jul; 88(1):101-7. PubMed ID: 7385013 [TBL] [Abstract][Full Text] [Related]
27. Salivary secretion in reflux esophagitis. Sonnenberg A; Steinkamp U; Weise A; Berges W; Wienbeck M; Rohner HG; Peter P Gastroenterology; 1982 Oct; 83(4):889-95. PubMed ID: 7106518 [TBL] [Abstract][Full Text] [Related]
28. The defense mechanisms of the esophagus. Jamieson GG; Duranceau AC Surg Clin North Am; 1983 Aug; 63(4):787-99. PubMed ID: 6351294 [TBL] [Abstract][Full Text] [Related]
30. Saliva transport to the distal esophagus. Dantas RO; Oliveira RB; Aprile LR; Hara SH; Sifrim DA Scand J Gastroenterol; 2005 Sep; 40(9):1010-6. PubMed ID: 16211700 [TBL] [Abstract][Full Text] [Related]
31. Saliva transit in patients with gastroesophageal reflux disease. Cassiani RA; Mota GA; Aprile LR; Dantas RO Dis Esophagus; 2015 Oct; 28(7):673-7. PubMed ID: 25082357 [TBL] [Abstract][Full Text] [Related]
32. Reflux esophagitis patients in Singapore have motor and acid exposure abnormalities similar to patients in the Western hemisphere. Ho KY; Kang JY Am J Gastroenterol; 1999 May; 94(5):1186-91. PubMed ID: 10235190 [TBL] [Abstract][Full Text] [Related]
33. Esophageal motor activity in children with gastro-esophageal reflux disease and esophagitis. Chitkara DK; Fortunato C; Nurko S J Pediatr Gastroenterol Nutr; 2005 Jan; 40(1):70-5. PubMed ID: 15625430 [TBL] [Abstract][Full Text] [Related]
34. Esophageal acid clearance during sleep in patients with Barrett's esophagus. Orr WC; Lackey C; Robinson MG; Johnson LF; Welsh JD Dig Dis Sci; 1988 Jun; 33(6):654-9. PubMed ID: 3371137 [TBL] [Abstract][Full Text] [Related]
35. [The role of esophageal sphincter tonus and of gastric motility in the extent of reflux esophagitis]. Cogliandolo A; Gulino FM; Pustorino S; Migliorato D; Bottari M; Saitta FP; Micali B Minerva Chir; 1992 Jan; 47(1-2):11-7. PubMed ID: 1553047 [TBL] [Abstract][Full Text] [Related]
36. Proximal migration of esophageal acid perfusions during waking and sleep. Orr WC; Elsenbruch S; Harnish MJ; Johnson LF Am J Gastroenterol; 2000 Jan; 95(1):37-42. PubMed ID: 10638556 [TBL] [Abstract][Full Text] [Related]
37. Effects of omeprazole on mechanisms of gastroesophageal reflux in childhood. Cucchiara S; Minella R; Campanozzi A; Salvia G; Borrelli O; Ciccimarra E; Emiliano M Dig Dis Sci; 1997 Feb; 42(2):293-9. PubMed ID: 9052509 [TBL] [Abstract][Full Text] [Related]
38. Effect of cisapride on secondary peristalsis in patients with gastroesophageal reflux disease. Holloway RH; Penagini R; Schoeman MN; Dent J Am J Gastroenterol; 1999 Mar; 94(3):799-803. PubMed ID: 10086669 [TBL] [Abstract][Full Text] [Related]
39. Impaired esophageal emptying in reflux disease. Lin S; Ke M; Xu J; Kahrilas PJ Am J Gastroenterol; 1994 Jul; 89(7):1003-6. PubMed ID: 8017356 [TBL] [Abstract][Full Text] [Related]